• Protocol E 2020-A001-319: A 24 week, Multicenter, randomized, double-blind, Placebo controlled Evaluation of the Efficacy, Safety and Tolerability of Donepezil Hydrochloride (E 2020) in Patients with Dementia Associated with Cerebro Vascular Disease.